IVF startup GonGlobal raises $1.2M for needle-free fertility treatments backed by Innovation Victoria and RMIT University.
Amount Raised
A$1.2 Million
Round Type
Seed
Investors
Description
GonGlobal, a biotech startup developing needle-free IVF treatments, has raised $1.2 million in new funding. The round was backed by Innovation Victoria via its University Innovation Platform, with RMIT University matching $500,000 and a private investor contributing $200,000. The funding will accelerate development of GonGlobal's Ovulair drug delivery system, an inhaled alternative to IVF injections designed to make fertility treatment less invasive and more precise. The company was founded by Ellen Gonda and her father Dr Igor Gonda, inspired by Ellen's personal experience with IVF.
Quick answer
GonGlobal raised A$1.2 Million in a Seed round, dated September 2, 2026. Investors: RMIT University and Innovation Victoria. GonGlobal is based in Australia.
- How much did GonGlobal raise?
- GonGlobal raised A$1.2 Million in a Seed round on September 2, 2026.
- Who invested in GonGlobal?
- RMIT University and Innovation Victoria are named as investors in this round.
- What does GonGlobal do?
- GonGlobal is a biotech startup developing needle-free IVF treatments through an inhaled drug delivery system called Ovulair.
- Where is GonGlobal based and how big is it?
- GonGlobal is based in Australia. Fundz records about 2 employees.
- Who are the decision-makers at GonGlobal?
- Fundz holds 1 contact at GonGlobal, including the Co-Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as GonGlobal that raised within 45 days of this round, from Fundz verified event records.
- Vitonnix raised an undisclosed amount (Seed) on October 17, 2026.
- GenSight Biologics raised $1.1M (Post-IPO Equity) on October 16, 2026.
- Microbiotica raised $48M (Series C) on October 16, 2026.
- Unravel Health raised $3.3M (Seed) on October 16, 2026.
- Estuary Biotherapeutics raised $93M (Series A) on October 16, 2026.
- Bioliberty raised $3.3M (Series A) on October 16, 2026.
Who to call at GonGlobal, and when
A new round usually means GonGlobal is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GonGlobal raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GonGlobal, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GonGlobal. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GonGlobal raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
GonGlobal raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.